Taking center stage in the #BCNHPVCourse closing block, @JPalefsky, Maite Garcia @CHUAC_Sergas and @adriacurran explore the ANCHOR study, anal dysplasia management and future training standards.
Thanks to all speakers and participants for making this 10th edition a success! 🙌
🔍 Together, @mdelpino.bsky.social, Alfonso Cabello
@Hospital_FJD and Joaquín Burgos @vallhebron.com
will address key clinical controversies in BLOCK II: HPV management in immunocompetent women, anal HSIL treatments, and anal dysplasia screening. #HPV #AnalDysplasia
🔬 BLOCK I takes us from bench to bedside. Exploring #HPV types in anal dysplasia across risk groups, advances in therapeutic vaccines, and CRISPR-based approaches for HPV treatment.
With @AngelikaRiemer, Laia Bruni @ICO_oncologia & Miquel Angel Pavón @hbellvitge #BCNHPVCourse
🚀 The 10th edition of #BCNHPVCourse is underway at @hubsociaty.bsky.social lbcn!
Adrià Curran @vallhebron.com & @ParesDavid welcome an outstanding international faculty for a day of discussions on anal dysplasia, HPV-related disease, innovation and future strategies in HPV care. #HPV
🫀Vuelve el curso Hands-on en Resonancia Magnética Cardíaca con su 4ª edición.
Actualiza tus conocimientos junto a especialistas y refuerza tus habilidades mediante sesiones prácticas y casos reales.
🔜 23 de octubre | Presencial
👉 Reserva tu plaza: scienhub.org/es/activity/...
🧬 Explore the future of HIV research at #HotTopicsInHIV
Leading researchers will share the latest insights on viral reservoirs, immunotherapies, CAR-T cells, and novel strategies towards long-term remission.
🗓️ 12 Nov | Barcelona
✅ Free registration: scienhub.org/en/activity/...
📸 That's a wrap on the 9th #HIVClinicalTopics!
A huge thank you to all attendees, speakers and sponsors @ViiVHC, @GileadSciences and @MSDEspana for making this edition such a success.
See you next year! 🌟
#HIVClinicalTopics
🧬 Complex cases, practical solutions.
Stefano Rusconi #LaStatale tackles HIV resistance, while Susanne Dam Poulsen #Rigshospitalet focuses on cardiovascular and metabolic challenges in long-term HIV care. #HIVClinicalTopics
Another good day ahead, starting with discussion about PrEP and asymptomatic screening #hivclinicaltopics @scienhub-org.bsky.social
🔥 One of the hottest discussions at #HIVClinicalTopics:
Will generic dolutegravir transform the ART landscape?
🟢 Berta Torres / #BcnVih: Probably yes
🔵 Georg Behrens / #MHH: Not so much
Where do you stand? 👇
👥 As people with HIV live longer, care continues to evolve.
Thomas Levett (@DrTomLevett) explores a key question for the future: do we need dedicated ageing clinics within HIV units?
#HIVClinicalTopics #Ageing
🚀 Day 2 kicks off at #HIVClinicalTopics!
What's new in HIV prevention? Valeria Mazzotta #IRCCS reviews the latest developments in PrEP, while Gary Whitlock #56deanstreet shares key updates shaping STI management in 2026.
💬 Time for real-world learning.
Cristiana Oprea and Sofía Sábato (@fundaciolluita.bsky.social) lead interactive case discussions on HIV, mpox, STIs and opportunistic infections, bringing everyday clinical challenges to the table.
#HIVClinicalTopics
🩺Liver health takes center stage at #HIVClinicalTopics
Sanjay Bhagani and Felice Cinque explore HBV reactivation in tenofovir-free regimens and the growing impact of MASLD in people living with HIV.
Another year at #hivclinicaltopics @scienhub-org.bsky.social learning lots
A strong start! From the Top 10 game changers in #HIV science with Diva Trigo to the future of ART with Rajesh Gandhi and the latest epidemiological challenges in Europe with Juliana Reyes -Urueña @ecdc.europa.eu perspective.
#HIVClinicalTopics
🧬 Welcome to the 9th #HIVClinicalTopics Workshop in Barcelona!
Over the next two days, leading experts will share the latest updates in HIV treatment, prevention, ageing, resistance and emerging clinical challenges. Let's get started! 🚀
El estudio THALASSA 2.0 entra en su recta final con la última visita del último participante (LPLV). Gracias a todos los profesionales y participantes que han contribuido al desarrollo de este proyecto 🎉
🚨 La terapia CAR-T está redefiniendo el tratamiento del linfoma B de célula grande.
🎙️ El Dr. Alberto Mussetti (@ICOoncologia) compartirá las claves en la jornada Inmunoterapia en Hematología.
🗓️ 5 nov | 📍 @hubsocialbcn
👉 scienhub.org/es/activity/...
El #ProgramaCounselling 2026 entra en su recta final! 🚀
Si te gustaría formar parte de la próxima edición de estas tutorías personalizadas, escríbenos a [email protected].
